Buddhist Understanding and Reduction of Myanmar Experiences of HIV Stigma and Exclusion

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

• Ages 18 years and older
• All sexes
• No healthy volunteers
• Adult, Older adult

Trial locations and contacts

2 sites in 2 countries.

About this study

Conditions

Hiv, Stigma, Social, Mindfulness

Being tested

Stigma reduction

Keywords

stigma, Mindfulness, Myanmar

Medical subject headings

Acquired Immunodeficiency Syndrome, Social Stigma

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

• Stigma reductionBehavioural

  The intervention is modularized to have eight weekly sessions of 2-hour group discussions, led by a trained facilitator. The facilitator applies the principle of CBT and provides psychoeducation to promote the awareness and understanding of HIV stigma as well as training to help participants acquire alternative coping skills, such as relaxation techniques.

What is being measured

The primary outcome is the main question the study is designed to answer.

1. Change in Stigma Score From Baseline to End of Intervention in Protocol Group

   Perceived Stigma Scale (PSS). Each item is measured using a 4-point Likert scale and the scale contains four factors: personalized stigma (18 items, subscore total 18-72), disclosure concerns (12 items, subscore total 12-48), negative self-image (9 items, subscore total 9-36), and concern with public attitudes about people with HIV (12 items, subscore total 12-48). Each factor is scored separately, with total score is computed by summing all 40 items, with a minimum total PSS score of 40 and a maximum possible score of 160. Raw PSS scores were transformed into Stigma scores 1-4. Higher scores reflect higher levels of perceived stigma.

   Measured: Baseline and 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

1. First posted18 Nov 2021
2. Study start1 Jul 2020
3. Primary completion19 Nov 2023
4. Study completion30 Apr 2024

Resources

• Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
• Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
• Other trials for HivStudies of the same condition, open and under way.
• More trials run by University of California, Los AngelesThe sponsor's other registered studies.
• What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.